ATAC
Live / Registered — Registered (as of 01 Nov 2022)
What this means for you
Registered since 01 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88439354
- Registration number
- 6886783
- Mark type
- Stylized text
- Filed
- 21 May 2019
- Published for opposition
- 16 Aug 2022
- Registered
- 01 Nov 2022
- Attorney of record
- Todd A. Sullivan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, anti-cancer and immunosuppression preparations; pharmaceuticals, namely, anti-cancer and immunosuppression preparations; chemico-pharmaceutical preparations, namely, chemical preparations for medical purposes for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances, namely, pharmaceutical products for the treatment of cancer and immunosuppression; pharmaceutical preparations, namely, anti-cancer preparations for veterinary use; chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer and immunosupression; pharmaceutical preparations for human use, namely, pharmaceutical preparations for human use in the treatment of cancer and immnunosupression; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; diagnostic preparations for veterinary purposes; clinical diagnostic reagents for medical use; diagnostic chemical reagents for medical use; anti-cancer drugs, namely, anti-cancer preparations; pharmaceutical compounds for treating cancer and immunosuppression; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals, namely, anti-cancer preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; antibodies being pharmaceutical preparations for the treatment of cancer and immunosuppression; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression with agents including amatoxin
- Class 042 — Scientific and technological services: Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; provision of medical research services; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; pharmaceutical research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific laboratory services relating to the production of monoclonal antibodies; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical advice; pharmaceutical consultation services; consultancy and information services relating to pharmaceutical products; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression
Owner
- Heidelberg Pharma Research GmbH, Ladenburg, DE
- Heidelberg Pharma Research GmbH, Ladenburg, DE
- Heidelberg Pharma Research GmbH, Ladenburg, DE
Prosecution history
- 04 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 04 Feb 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 04 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 16 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Aug 2022 — PUBLISHED FOR OPPOSITION
- 27 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE